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Abstract
Over the past several years, the death rate associated with drug poisoning has increased by over 
300% in the U.S. Drug poisoning mortality varies widely by state, but geographic variation at the 
substate level has largely not been explored. National mortality data (2007–2009) and small area 
estimation methods were used to predict age-adjusted death rates due to drug poisoning at the 
county level, which were then mapped in order to explore: whether drug poisoning mortality 
clusters by county, and where hot and cold spots occur (i.e., groups of counties that evidence 
extremely high or low age-adjusted death rates due to drug poisoning). Results highlight several 
regions of the U.S. where the burden of drug poisoning mortality is especially high. Findings may 
help inform efforts to address the growing problem of drug poisoning mortality by indicating 
where the epidemic is concentrated geographically.
Keywords
Empirical Bayes prediction; Spatial variation; Overdose; Cold spots
1. Introduction
The burden of mortality and morbidity associated with drug poisoning represents a growing 
public health concern in the U.S. Poisoning has recently overtaken motor vehicle crashes as 
the leading cause of injury death in the U.S.; the death rate associated with drug poisoning 
has increased by approximately 300% over the past several decades (Warner et al., 2011). 
Increases in deaths due to opioid analgesics have been particularly large for U.S. women, 
rising by 415% since 1999 (Centers for Disease Control and Prevention, 2013). Opioid 
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analgesics contribute to more than three in four poisoning deaths; and the use and misuse of 
prescription drugs, particularly opioid analgesics, has increased in parallel with drug 
poisoning mortality (Centers for Disease Control and Prevention, 2011, 2013). There is wide 
variation at the state level with respect to age-adjusted drug poisoning death rates (Centers 
for Disease Control and Prevention, 2011; Paulozzi and Ryan, 2006; Warner et al., 2011). 
Extremely high annual rates have been observed for New Mexico (30.8 per 100,000), West 
Virginia (27.6 per 100,000), Alaska (24.2 per 100,000), Nevada (21.0 per 100,000), and 
Utah (20.8 per 100,000) (Centers for Disease Control and Prevention, 2011; Warner et al., 
2011). However, variation within states has largely not been examined.
A few studies have looked at variation at the sub-state level, but have focused on limited 
geographic areas such as New York City, Rhode Island, North Carolina, New Hampshire 
and Connecticut (Cerdá et al, 2013; DiMaggio et al., 2008; Green and Donnelly, 2011; 
Green et al., 2011; Hester et al., 2012; Modarai et al., 2013). Some studies have suggested 
that drug poisoning mortality disproportionately affects rural areas as compared to urban 
(Paulozzi and Xi, 2008), but it is possible that urban–rural differences may be influenced by 
underlying geographic or regional patterns. The objectives of this study were to use spatial 
statistical tools to examine county-level variation in drug poisoning mortality and highlight 
areas of the U.S. where drug-related poisoning deaths are higher or lower than expected, 
with the goal of informing efforts to address this growing epidemic.
2. Materials and methods
2.1. Data and empirical Bayes estimates
Data on drug poisoning deaths were obtained from the 2007–2009 National Vital Statistics 
Multiple Cause of Death Files (Kochanek et al., 2011; Minino et al., 2011). Deaths were 
classified using the International Classification of Diseases (ICD), Tenth Revision (ICD-10). 
Age-adjusted death rates (AADR) due to drug poisoning were calculated by county and year 
using the direct method and the 2000 standard population (Kochanek et al., 2011; Minino et 
al., 2011). Since drug poisoning deaths are a rare event, calculating county-level drug 
poisoning death rates based on crude rates will produce highly unstable estimates. We 
therefore used small area estimation techniques to produce stable county-level estimates of 
age-adjusted death rates (AADR) associated with drug poisoning for 3141 counties in the 
U.S., 2007–2009. Small area estimation techniques are increasingly being used in disease 
mapping to produce reliable estimates for areas where population sizes are small or events 
are infrequent. We review these methods briefly here. Details on the methods can be found 
in Supplemental Appendix A and has been recently described elsewhere (Rossen et al., 
2013).
Two-stage mixed effects models were used to estimate county-level drug poisoning AADRs, 
due to the highly non-normal distribution of poisoning death rates which are highly zero-
inflated and right-skewed (Afifi et al., 2007; Alfo and Maruotti, 2010; Baughman, 2007; 
Kowalski et al., 2003; Li et al., 2011; Wang, 2010; Xie et al., 2004), as approximately 24% 
of counties had zero deaths in any given year. The first stage modeled the probability of 
observing no deaths, and the second stage modeled the expected log-transformed age-
adjusted death rate, conditional on having a death. Mixed effects models are commonly used 
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in small area estimation, as they can be used to predict empirical Bayes estimates which 
borrow information across clusters to shrink extreme values and provide stable small area 
estimates (Pfefferman, 2002; Rao, 2003; Saei and Chambers, 2003; Skrondal and Rabe-
Hesketh, 2009).
We included county-level random intercepts and fixed effects in both steps of the model 
using the Generalized Linear and Latent Mixed Modeling (GLLAMM) procedures in Stata 
12.1 SE (Rabe-Hesketh et al., 2004; StataCorp, 2011). Fixed effects included a variety of 
county-level covariates drawn from several sources, including socio-demographic and 
economic characteristics, crime, urban–rural classification, and health-related data (Federal 
Bureau of Investigation, 2000), National Center for Health Statistics Urban–Rural 
Classification Scheme (Ingram and Franco, 2012) and the decennial Census of the U.S. 
population (U.S. Department of Commerce, Bureau of the Census, 2000)) for the year 2000. 
A list of included covariates can be seen in Table 1.
Metropolitan counties were classified to one of four levels based on the population size and 
proximity to urban centers: large core and large fringe (population >1 million); medium 
(population 250,000–999,999); and small (population <250,000). Non-metropolitan counties 
were classified as micropolitan or non-core. In this analysis, rural refers to non-core 
counties. Additionally, models included the estimated proportions of the population 
reporting nonmedical use of prescription medication as assessed by the National Survey on 
Drug Use and Health obtained from the Substance Abuse and Mental Health Services 
Administration for 344 substate regions, 2007–2008 (Substance Abuse and Mental Health 
Services Administration, 2009). Finally, the percent of deaths for which the final cause of 
death was pending (at the state level) was also included because poisonings account for a 
large proportion of pending deaths (Warner and Chen, 2012). The posterior predictions from 
each stage of the model incorporate both an empirical Bayes estimate for each county, plus 
the linear (or log-linear) prediction from the fixed effects portions of the models (Skrondal 
and Rabe-Hesketh, 2009). This auxiliary information was included to improve the predictive 
power of the models (Pfefferman, 2002; Saei and Chambers, 2003). Overall, 74% of the 
between-county variance in the likelihood of reporting at least one drug poisoning fatality 
was explained by the included covariates, as was 42% of the between-county variance in the 
age-adjusted death rates due to drug poisoning. County-level drug poisoning AADRs were 
then estimated by multiplying the predicted posterior probability of having a death obtained 
from the first step with the posterior mean drug-related AADR obtained from the second 
step. These predicted drug poisoning AADRs were then merged with U.S. Census Tiger/
Line files and mapped using ArcGIS 10.1 (ESRI, 2011).
2.2. Spatial statistical tools
2.2.1. Global index of spatial autocorrelation – Moran’s I—Global indexes of 
spatial autocorrelation were used to assess the similarity, or spatial dependence, across 
counties with respect to drug poisoning mortality. In other words, do counties with similar 
drug poisoning AADRs tend to be located close together or are drug poisoning AADRs 
randomly distributed across counties in the U.S.? The Global Moran’s I statistic is evaluated 
in terms of a null hypothesis that AADRs by county are spatially random (ESRI, 2011; 
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Waller and Gotway, 2004). From Waller and Gotway (2004), the Global Moran’s I statistic 
for spatial autocorrelation is given as
where zi is the deviation (xi−X) of AADR’s for county i from the overall mean, ωij is the 
spatial weight between county i and j (described below), n is equal to the total number of 
counties, and SO is the aggregate of all the spatial weights:
The zi-score for the statistic is
where E[I] = −1/(n − 1) and V[I] = E[I2] − E[I]2.
High values of the Moran’s I and corresponding z-scores greater than −1.96 indicate that 
there is statistically significant clustering across the study area (p < 0.05). Low values of the 
Moran’s I and z-scores less than −1.96 indicate that there is statistically significant regularity 
(nearby counties have very different AADRs). Moran’s I can be thought of as a spatially 
weighted form of Pearson’s correlation coefficient (Waller and Gotway, 2004).
2.2.2. Conceptualization of spatial relationships—There are several ways to define 
ωij, the spatial weight between county i and j. We explored three methods, inverse distance, 
K nearest neighbors and Delaunay triangulation. In the inverse distance conceptualization, 
every county is assumed to be a neighbor of every other county, and the influence of 
counties decays with increasing distance (ESRI, 2011). Since our study area consisted of the 
entire U.S., this conceptualization is problematic because large distances between counties 
result in very small weights and “salt-and-pepper” style maps. Additionally, the 
heterogeneity in county sizes across the U.S. leads to small counties with close neighbors 
being given greater weight than larger counties with neighbors that are farther away. To 
circumvent the issue of heterogeneous county sizes and the large study area, we explored the 
K nearest neighbors option, where a general rule of thumb is to evaluate each county in the 
context of a minimum of eight neighbors (ESRI, 2011). However, because we found several 
isolated counties with fewer than eight neighbors (i.e., some counties in Hawaii and Alaska), 
we ultimately proceeded with the Delaunay triangulation conceptualization of spatial 
relationships. Delaunay triangulation specifies natural neighbors for a set of counties by 
creating Voronoi triangles from county centroids; nodes connected by a triangle edge are 
considered neighbors. Fig. 1 illustrates the Delaunay triangulation method.
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This method works well when there are isolated features or heterogeneity in county size 
(ESRI, 2011). This method ensures that every county has at least one neighbor but utilizes 
the distribution of the data for determining how many neighbors each county gets. We 
created a spatial weights matrix file using the Delaunay triangulation conceptualization of 
spatial relationships. Sensitivity analyses were conducted using the eight-nearest-neighbors 
conceptualization.
2.2.3. Local indicators of spatial association – Getis-Ord —While global 
indexes of spatial autocorrelation assess whether there is clustering across the study area, 
local indicators of spatial association can be used to identify specific clusters of high or low 
drug poisoning AADRs (Waller and Gotway, 2004). We used the Getis-Ord  statistic to 
identify significant clusters of counties with high or low AADRs (ESRI, 2011). The Getis-
Ord  statistic generates a z-score and corresponding p-value for each data point, where z-
scores greater than −1.96 indicate a significant “hot spot” and z-scores lower than 1.96 
indicate a significant “cold spot” (p < 0.05). From ESRI (2011), the Getis-Ord  statistic is 
calculated as
where xj is the AADR’s for each county j, ωij is the spatial weight between county i and j, n 
is equal to the total number of features and
and
3. Results
The predicted mean county-level AADR for the years 2007–2009 was 30.76 per 100,000 
population (SD: 16.08), and ranged from a low of 0.45 to a high of 128.48 per 100,000 
population. The raw county-level AADRs ranged from 0 to 222.4 per 100,000 population 
(SD: 26.5). The differences between the range in estimated AADRs and the raw rates were 
small; however, the estimated AADRs were much less variable. Fig. 2 depicts the predicted 
drug poisoning AADRs across 3141 counties for the years 2007–2009. Approximately 
7.64% of counties had AADRs less than 10 per 100,000 population, while 11.37% of 
counties had AADRs greater than 50 per 100,000 population.
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3.1. Clustering of drug poisoning mortality – Moran’s I
The Global Moran’s I was 0.55, with a corresponding z-score of 53.53, suggesting that there 
was significant spatial autocorrelation of county-level drug poisoning AADRs (p < 0.05). In 
other words, across the U.S., counties with similar drug poisoning AADRs tend to locate 
closer to one another than we would expect by random chance.
3.2. Hot and cold spots – Getis-Ord 
Significant clusters of counties with high (hot spots) and low (cold spots) AADRs, as 
assessed by the Getis-Ord  tool can be seen in Fig. 3.
Sensitivity analyses using eight-nearest-neighbors produced very similar results (not 
shown). While some previous studies have suggested that drug poisoning AADRs are higher 
in rural areas as compared to more urban areas, we observed significant hot spots and cold 
spots in rural areas. Significant hot spots were seen along the North Pacific coast (i.e., 
northern California, Washington), the Southwest (i.e., Nevada, Arizona and New Mexico), 
Oklahoma, Appalachia (i.e., areas of Kentucky, Tennessee, West Virginia, Virginia, North 
Carolina), and the Gulf coast (i.e., the coast of Louisiana, Mississippi, and Florida). Cold 
spots were identified across the Central Plains (i.e., North and South Dakota, Nebraska, 
Kansas), Texas, and regions of Alaska. Results indicate that rural areas represent both hot 
and cold spots in drug poisoning death rates. Rural areas across the Central Plains states, 
Texas, and Alaska represent significant cold spots; while rural areas in Appalachia, Northern 
California, Oklahoma, and New Mexico represent significant hot spots.
4. Discussion
There is substantial geographic variation in age adjusted death rates (AADR) due to drug 
poisoning across the U.S. Results of global tests of spatial autocorrelation (i.e., Moran’s I) 
confirm that drug poisoning mortality exhibits spatial dependence. In other words, across the 
entire U.S., counties with high drug poisoning AADRs tend to locate closer together than we 
would expect at random. Conversely, counties with low levels of drug poisoning mortality 
also tend to cluster together geographically. Using local indicators of spatial association 
(i.e., Getis Ord ), we were able to identify several hot and cold spots across the U.S. that 
represent clusters of counties with significantly high or low drug poisoning death rates. The 
main hot spots detected occurred along the North Pacific coast (i.e., northern California, 
Washington), the Southwest (i.e., Nevada, Arizona and New Mexico), Oklahoma, 
Appalachia (i.e., areas of Kentucky, Tennessee, West Virginia, Virginia, North Carolina), 
and the Gulf coast (i.e., the coast of Louisiana, Mississippi, and Florida). Cold spots were 
identified across the Central Plains (i.e., North and South Dakota, Nebraska, Kansas), Texas, 
and regions of Alaska.
Previous research has indicated that drug poisoning mortality is a major concern for rural 
areas, and particularly for Appalachia (Centers for Disease Control and Prevention, 2011; 
Frosch, 2012; Hiaasen, 2009; Paulozzi and Ryan, 2006; Rossen et al., 2013; Wunsch et al., 
2009). Our results are partially consistent with these patterns, as we did observe a hot spot of 
extremely high death rates due to drug poisoning in the Appalachian region. Hot spots were 
Rossen et al. Page 6
Health Place. Author manuscript; available in PMC 2015 November 25.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
also observed for rural regions of Northern California, New Mexico, Oklahoma, Arkansas, 
and Michigan. However, we also observed cold spots, or significantly low AADRs due to 
drug poisoning, across large swaths of rural counties in the central U.S. For example, cold 
spots in North and South Dakota, Nebraska, Kansas, Minnesota, Iowa, and Texas were 
predominantly in rural areas. In contrast to previous research suggesting that drug poisoning 
mortality is disproportionately high in rural areas as opposed to more urban areas; our 
results indicate that rural areas of the U.S. represented some of the lowest and highest drug 
poisoning death rates. As previous research has largely not examined spatial variation in 
drug poisoning mortality, results of this study highlight that the variation in drug poisoning 
mortality appears to be influenced heavily by geography as opposed to just urban–rural 
classification. One analysis of opioid-related deaths in New Hampshire reported that there 
was significant clustering of poisoning deaths across Zip Code Tabulation Areas, and that 
death rates were associated with lower area income levels and higher rates of employment-
related disability, but not with rural status (Hester et al., 2012). Hester et al. (2012) 
suggested that geographic factors such as proximity to regions where opioids are highly 
available might be more critical to spatial patterning than population density.
Substantial geographic variation in drug poisoning mortality was apparent, as clear clusters 
of counties with extremely high and low drug poisoning AADRs emerged. These clusters 
often crossed state borders, as could be seen in the Appalachian region and the hot spots 
across the Pacific coast and Southwest U.S., as well as the large cold spots that were seen in 
the central U.S. More research is needed to explore the drivers of these geographic patterns, 
as it remains unclear why certain areas of the U.S. are experiencing extremely high (or low) 
drug poisoning death rates. A variety of regional-, county-, or neighborhood-level 
characteristics could be associated with geographic variation in drug poisoning mortality. A 
recent analysis reported that the amount of opioids prescribed was highest in Nevada, 
Florida and the Appalachian states; similar to some of the geographic patterns in drug 
poisoning mortality observed in this study (McDonald et al., 2012). Maps of the prevalence 
of nonmedical use of pain relievers from the National Survey of Drug Use and Health also 
overlap with drug poisoning mortality in many areas (Substance Abuse and Mental Health 
Services Association, 2012). For example, states on the Pacific Coast, South West, and 
Oklahoma have reported high prevalence rates of nonmedical use of pain relievers, while 
North and South Dakota have relatively low prevalence rates. A spatial analysis of hot and 
cold spots of drug use in the U.S. (also using data from the National Survey of Drug Use and 
Health) generated results that are similar in some regards to those described in the present 
analysis (Gopal et al., 2008). For example, North and South Dakota appeared to represent 
cold spots when mapping rates of abuse or dependence on illicit drugs (excluding 
marijuana), while hot spots were identified in parts of California, the South West, 
Oklahoma, and some Appalachian states (Gopal et al., 2008). However, that analysis also 
suggested that parts of Texas represented a hot spot, and also identified Pennsylvania and 
Maryland as cold spots, in contrast to the present study of drug poisoning mortality. Results 
may differ for several reasons. Gopal et al. (2008) utilized data from 2002 to 2004 and 
patterns may have changed over time, self-report data may produce different spatial patterns 
as compared to data from death certificates, and/or geographic variation in drug abuse or 
dependence may not cohere with that of mortality due to drug poisoning. As few studies 
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have looked at variation at the sub-state level (Cerdá et al., 2013; DiMaggio et al., 2008; 
Green and Donnelly, 2011; Green et al, 2011; Hester et al., 2012; Modarai et al., 2013; 
Rossen et al., 2013) the drivers of spatial variation in drug poisoning mortality remain 
unclear. Further research is needed to elucidate the causal factors that contribute to these 
geographic patterns.
This study has a few limitations. It is possible that drug poisoning deaths were 
underestimated. There are many challenges to accurately classifying deaths due to drug 
poisoning and compiling this information on a national scale; a process which relies heavily 
on professional judgment and varying levels of evidence and resources available to medical 
examiners and coroners (Davis, 2013; Prescription Monitoring Program Center of 
Excellence at Brandeis, 2011; Szalavitz, 2010; Warner et al., 2013). Therefore, there may be 
some misclassification bias when using federal vital statistics to examine drug poisoning 
deaths (Dasgupta et al., 2008). Poisoning deaths are disproportionately represented among 
the cases where the cause of death remains pending in the death certificate data, so although 
we included the percent of pending cases at the state level as a covariate in our models, it is 
possible that pending cause of death disproportionately represents drug poisoning mortality 
and varies by county; additionally, other types of misclassification may vary geographically, 
potentially affecting our examinations of county-level spatial variation (Dasgupta et al., 
2008; Landen et al., 2003). This kind of misclassification would be more likely to contribute 
to the incorrect identification of cold spots, though it could also result in the failure to detect 
a hot spot particularly in sparsely populated areas where a single death can substantially 
influence the AADR for that county. The purpose of using small area estimation techniques 
was to stabilize these extreme or unreliable values. The advantage of using small area 
estimation is that information is ‘borrowed’ across units to produce reliable estimates when 
only small samples are available in certain areas, such as in rural counties. The inclusion of 
various covariates derived from many data sources served to improve these predictions, and 
explained a large portion of the between-county variance in the likelihood of observing a 
drug poisoning fatality and the age-adjusted death rate due to drug poisoning. However, 
there was a degree of unexplained variance, which could be the result of residual spatial 
variation or omitted variables such as access to various types of drugs, or other factors 
related to local drug markets, physician prescribing patterns, or the prevalence of doctor-
shopping or drug-diversion (National Research Council, 2010; Paulozzi and Ryan, 2006). 
Future studies should examine these potential determinants to explore whether these factors 
may help to explain some of the clusters of extremely high drug poisoning death rates 
observed in this study.
Future studies should also explore spatial patterns by type of drug, as findings may differ for 
illicit or prescription drugs (Cerdá et al, 2013; Dasgupta et al., 2008; Hester et al., 2012; 
National Research Council, 2010). As this study examined drug poisoning overall, it 
remains unclear how spatial patterns by drug type might overlap or remain distinct, and how 
the overall spatial patterning might be influenced. For example, a report on drug poisonings 
in Connecticut reported that heroin fatalities were more likely to occur in urban areas, while 
prescription opioid fatalities were more likely to occur in small towns (Green et al., 2011). 
Dasgupta et al. (2008) reported distinct geographic patterns for heroin overdoses as 
compared to prescription opioid deaths, and variation between metropolitan and non-
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metropolitan areas in death rates due to alcohol, benzodiazepines, antidepressants, 
prescription opioids, and illicit drugs. Recent studies have also shown that there are changes 
in drug use patterns with nonmedical users of prescription opioids transitioning to heroin use 
(Jones, 2013). For the purposes of this analysis, we examined overall drug poisoning 
mortality for two reasons. First, because previous studies have reported that the 
classification of deaths due to a specific drug are more prone to error than categorizing 
overall drug poisoning in vital statistics (Landen et al., 2003). Second, because the specific 
drug type was not available for 25% of the drug poisoning deaths, and it varied by state, 
ranging from approximately 65% to less than 1% missing data (Warner et al., 2013).
Finally, there is no ideal characterization of spatial relationships when analyzing hot spots, 
particularly when examining a large geographic region such as the entire U.S. Due to the 
presence of several island counties in Hawaii and Alaska and general unevenness of county 
size (in terms of geographic area), we used Delaunay triangulation, which creates weights 
based on a county’s natural neighbors and ensures every county has a least one neighbor. 
We also ran analyses using eight nearest neighbors, which produced results largely similar 
to those reported here. However, there are alternative characterizations that could be 
explored, such dividing the U.S. into regions and examine each separately to ensure some 
consistency in county size. While counties may not be the ideal unit to examine drug 
poisoning mortality, as there is likely substantial variation at the sub-county level, the data 
are compiled for the nation by county. Results are subject to potential biases related to the 
modifiable areal unit problem and ecological fallacies (Holt et al., 1996).
This study has a number of strengths. We used small area estimation techniques to generate 
stable estimates of age adjusted death rates due to drug poisoning at the county level. It is 
the first study to highlight spatial clusters of high and low drug poisoning death rates in the 
U.S. and was able to identify hot or cold spots that span multiple states. Previous studies 
have focused on limited geographic areas such as a single state (Cerdá et al, 2013; 
DiMaggio et al., 2008; Green and Donnelly, 2011; Modarai et al., 2013), have not used 
small area estimation methods, or spatial statistical tools to examine geographic variation in 
drug poisoning mortality across the U.S.
5. Conclusions
In sum, there is substantial geographic variation in drug poisoning mortality across the U.S. 
Counties with high and low death rates due to drug poisoning tend to cluster together more 
than we would expect by chance. Several hot spots were detected, notably, Appalachia, 
areas of Northern California, Nevada, Arizona and New Mexico, Oklahoma, Florida, and 
parts of the Gulf Coast. Cold spots were observed across the North-Central U.S., and parts 
of Texas. As rural areas contributed to both hot and cold spots, no uniform pattern emerged 
by rural or urban classification. Examining geographic variation in drug poisoning death 
rates is critical to future efforts aimed at understanding and targeting this growing epidemic.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Appendix A. Supplementary material
Supplementary data associated with this article can be found in the online version at http://
dx.doi.org/10.1016/j.healthplace.2013.11.005.
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Fig. 1. 
Example of Delaunay triangulation. Counties in light gray are considered neighbors of the 
county shaded dark gray.
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Fig. 2. 
Predicted drug poisoning AADR by county, 2007–2009.
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Fig. 3. 
Hot and cold spots in drug poisoning mortality, 2007–2009
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Table 1
Covariates included in empirical Bayes estimate modeling of age-adjusted death rates due to drug poisoning in 
the U.S., 2007–2009.
Region of the country (Division: New England, Mid-Atlantic, East North Central, West North 
Central, South Atlantic, East South Central, West South Central, Mountain, Pacific)
Median age
Percent black
Percent white
Percent Hispanic
Latitude and longitude of county centroid Square miles Percent Asian Percent other race
Population size Percent with less than HS education
Residential density Percent female headed households
Percent rural Number of MDs
Percent of land that is farm Number of hospitals
Median home value Percent on medicare
Percent household public assistance Percent on medicaid
Percent renter occupied housing Number in jail
Percent households with dividend income Number in juvenile detention
Percent English speaking Number homeless
Percent native Average percent humidity in July
Percent households without earnings Above the median arrests for drug sale
Above the median arrests for drug-related crimes Percent unemployed
Central, fringe, medium metropolitan, micropolitan, non-core/rural Percent of deaths with pending causes
Proportion of population reporting nonmedical prescription drug use
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